Federal Register Notice: FDA is seeking comments on a study examining the impact on consumer comprehension of inclusion of a toll-free number to report side effects in direct-to-consumer (DTC) prescription drug television advertisements. Comments should be submitted by 1/26/09. To view this notice, click here.
